148
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Minimum Alveolar Concentration-Awake of Sevoflurane is Decreased in Patients with Parkinson’s Disease: An Up-and-Down Sequential Allocation Trial

, , , , , , & ORCID Icon show all
Pages 129-137 | Published online: 15 Jan 2021

References

  • Draoui A, El Hiba O, Aimrane A, El Khiat A, Gamrani H. Parkinson’s disease: from bench to bedside. Rev Neurol. 2020;176:543–559. doi:10.1016/j.neurol.2019.11.00231928746
  • Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm. 2017;124(8):901–905. doi:10.1007/s00702-017-1686-y28150045
  • Collaborators GBDPsD. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):939–953. doi:10.1016/S1474-4422(18)30295-330287051
  • Xu XP, Yu XY, Wu X, et al. Propofol requirement for induction of unconsciousness is reduced in patients with Parkinson’s disease: a case control study. Biomed Res Int. 2015;2015:953729. doi:10.1155/2015/95372926495319
  • Wang JF, Xu XP, Yu XY, et al. Remifentanil requirement for inhibiting responses to tracheal intubation and skin incision is reduced in patients with Parkinson’s disease undergoing deep brain stimulator implantation. J Neurosurg Anesthesiol. 2016;28(4):303–308. doi:10.1097/ANA.000000000000022926368663
  • Song D, Joshi GP, White PF. Titration of volatile anesthetics using bispectral index facilitates recovery after ambulatory anesthesia. Anesthesiology. 1997;87(4):842–848. doi:10.1097/00000542-199710000-000189357886
  • White PF, Kehlet H, Neal JM, Schricker T, Carr DB, Carli F. The role of the anesthesiologist in fast-track surgery: from multimodal analgesia to perioperative medical care. Anesth Analg. 2007;104(6):1380–1396. (). doi:10.1213/01.ane.0000263034.96885.e117513630
  • Song JG, Cao YF, Yang LQ, et al. Awakening concentration of desflurane is decreased in patients with obstructive jaundice. Anesthesiology. 2005;102(3):562–565. doi:10.1097/00000542-200503000-0001415731594
  • Wu Y, Jin S, Zhang L, et al. Minimum alveolar concentration-awake of sevoflurane is decreased in patients with end-stage renal disease. Anesth Analg. 2019;128(1):77–82. doi:10.1213/ANE.000000000000367630044291
  • Yang C, Feng Y, Wang S, et al. Effect of sex differences in remifentanil requirements for inhibiting the response to a CO2 pneumoperitoneum during propofol anesthesia: an up-and-down sequential allocation trial. BMC Anesthesiol. 2020;20(1):35. doi:10.1186/s12871-020-0951-z32013877
  • Katoh T, Ikeda K, Bito H. Does nitrous oxide antagonize sevoflurane-induced hypnosis? Br J Anaesth. 1997;79(4):465–468. doi:10.1093/bja/79.4.4659389264
  • Bourgeois E, Sabourdin N, Louvet N, Donette FX, Guye ML, Constant I. Minimal alveolar concentration of sevoflurane inhibiting the reflex pupillary dilatation after noxious stimulation in children and young adults. Br J Anaesth. 2012;108(4):648–654. doi:10.1093/bja/aer45922265901
  • Niu B, Fang Y, Miao JM, et al. Minimal alveolar concentration of sevoflurane for induction of isoelectric electroencephalogram in middle-aged adults. Br J Anaesth. 2014;112(1):72–78. doi:10.1093/bja/aet28023975567
  • Cao Y, Zhang L, Peng X, et al. Increased minimum alveolar concentration-awake of Sevoflurane in women of breast surgery with sleep disorders. BMC Anesthesiol. 2020;20(1):17. doi:10.1186/s12871-020-0931-331959101
  • Paul M, Fisher DM. Are estimates of MAC reliable? Anesthesiology. 2001;95(6):1362–1370. doi:10.1097/00000542-200112000-0001411748393
  • Chen SQ, Ye HR, Chen YJ, Wang YW. MAC (EI) and MAC (awake) of sevoflurane in infants with obstructive jaundice. Paediatr Anaesth. 2014;24(3):282–289. doi:10.1111/pan.1232224330496
  • Goo EK, Lee JS, Koh JC. The optimal exhaled concentration of sevoflurane for intubation without neuromuscular blockade using clinical bolus doses of remifentanil: A randomized controlled trial. Medicine. 2017;96(9):e6235. doi:10.1097/MD.000000000000623528248887
  • Munson ES, Hoffman JC, Eger EI 2nd. Use of cyclopropane to test generality of anesthetic requirement in the elderly. Anesth Analg. 1984;63(11):998–1000. doi:10.1213/00000539-198411000-000066496985
  • Gold MI, Abello D, Herrington C. Minimum alveolar concentration of desflurane in patients older than 65 yr. Anesthesiology. 1993;79(4):710–714. doi:10.1097/00000542-199310000-000128214749
  • Sano T, Drummond JC, Patel PM, Grafe MR, Watson JC, Cole DJ. A comparison of the cerebral protective effects of isoflurane and mild hypothermia in a model of incomplete forebrain ischemia in the rat. Anesthesiology. 1992;76(2):221–228. doi:10.1097/00000542-199202000-000111736699
  • Quasha AL, Eger EI 2nd, Tinker JH. Determination and applications of MAC. Anesthesiology. 1980;53(4):315–334. doi:10.1097/00000542-198010000-000086107067
  • Brian JE Jr, Bogan L, Kennedy RH, Seifen E. The impact of streptozotocin-induced diabetes on the minimum alveolar anesthetic concentration (MAC) of inhaled anesthetics in the rat. Anesth Analg. 1993;77(2):342–345. doi:10.1213/00000539-199377020-000228346836
  • Allaouchiche B, Duflo F, Debon R, Tournadre JP, Chassard D. Influence of sepsis on minimum alveolar concentration of desflurane in a porcine model. Br J Anaesth. 2001;87(2):280–283. doi:10.1093/bja/87.2.28011493502
  • Emir UE, Tuite PJ, Oz G. Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS. PLoS One. 2012;7(1):e30918. doi:10.1371/journal.pone.003091822295119
  • Dharmadhikari S, Ma R, Yeh CL, et al. Striatal and thalamic GABA level concentrations play differential roles for the modulation of response selection processes by proprioceptive information. NeuroImage. 2015;120:36–42. doi:10.1016/j.neuroimage.2015.06.06626142275
  • O’Gorman Tuura RL, Baumann CR, Baumann-Vogel H. Neurotransmitter activity is linked to outcome following subthalamic deep brain stimulation in Parkinson’s disease. Parkinsonism Relat Disord. 2018;50:54–60. doi:10.1016/j.parkreldis.2018.02.01429472099
  • Griffith HR, Okonkwo OC, O’Brien T, Hollander JA. Reduced brain glutamate in patients with Parkinson’s disease. NMR Biomed. 2008;21(4):381–387. doi:10.1002/nbm.120317907264
  • Ishizeki J, Nishikawa K, Kubo K, Saito S, Goto F. Amnestic concentrations of sevoflurane inhibit synaptic plasticity of hippocampal CA1 neurons through gamma-aminobutyric acid-mediated mechanisms. Anesthesiology. 2008;108(3):447–456. doi:10.1097/ALN.0b013e318164cfba18292682
  • Sumikura H, Arendt-Nielsen L. MAC reduction after intrathecal coadministration of GABA (A) agonist and glutamate antagonist in rats. J Anesth. 2003;17(2):92–97.12903919
  • Antkowiak B. Different actions of general anesthetics on the firing patterns of neocortical neurons mediated by the GABA (A) receptor. Anesthesiology. 1999;91(2):500–511. doi:10.1097/00000542-199908000-0002510443614
  • Johnston RR, Way WL, Miller RD. The effect of CNS catecholamine-depleting drugs on dextroamphetamine-induced elevation of halothane MAC. Anesthesiology. 1974;41(1):57–61. doi:10.1097/00000542-197407000-000134275974
  • Nakao H, Ono J, Nogaya J, Yokono S, Yube K. The relationship of brain catecholamine levels to enflurane requirements among three strains of mice with different anesthetic sensitivities. J Anesth. 2001;15(2):88–92. doi:10.1007/s00540017003314566529
  • Segal IS, Walton JK, Irwin I, et al. Modulating role of dopamine on anesthetic requirements. Eur J Pharmacol. 1990;186(1):9–15. doi:10.1016/0014-2999(90)94055-32282937
  • Abdelmawgoud A, Rashwan S. Effect of preoperative oral amantadine on intraoperative anesthetic and analgesic requirements in female patients during abdominoplasty. Egyptian J Anaesthesia. 2019;29(1):7–11. doi:10.1016/j.egja.2012.09.001